Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction

Published:2022-03 Issue:12 Volume:79 Page:1129-1137
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ferreira João Pedro,Butler Javed,Zannad Faiez,Filippatos Gerasimos,Schueler Elke,Steubl Dominik,Zeller Cordula,Januzzi James L.,Pocock Stuart,Packer Milton,Anker Stefan D.

Funder

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

2. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

3. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

4. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial;Pfeffer;Circulation,2015

5. Spironolactone metabolites in TOPCAT—new insights into regional variation;de Denus;N Engl J Med,2017

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes;World Journal of Diabetes;2024-07-15

2. Early clinical outcomes and learning curve study of robot- assisted precision osteotomy in total knee arthroplasty in the context of ERAS;2024-06-13

3. Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?;Korean Circulation Journal;2024

4. Sodium glucose transporters inhibitors in the management of heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024

5. UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE;BMC Nephrology;2023-10-25